CSANZ Position Statement on the Evaluation of Patients Presenting With Suspected Acute Coronary Syndromes During the COVID-19 Pandemic

William A. Parsonage, Louise Cullen, David Brieger, Graham S. Hillis, Arthur Nasis, Nathan Dwyer, Sudhir Wahi, Sidney Lo, Martin Than, Andrew Kerr, Gerard Devlin, Derek K. Chew

Research output: Contribution to journalLetterpeer-review

1 Citation (Scopus)

Abstract

A pandemic of Coronavirus-19 disease was declared by the World Health Organization on March 11, 2020. The pandemic is expected to place unprecedented demand on health service delivery. This position statement has been developed by the Cardiac Society of Australia and New Zealand to assist clinicians to continue to deliver rapid and safe evaluation of patients presenting with suspected acute cardiac syndrome at this time. The position statement complements, and should be read in conjunction with, the National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Management of Acute Coronary Syndromes 2016: Section 2 ‘Assessment of Possible Cardiac Chest Pain’.

Original languageEnglish
Pages (from-to)e105-e110
Number of pages6
JournalInternational Journal of Pharmaceutics
Volume29
Issue number7
DOIs
Publication statusPublished - Jul 2020
Externally publishedYes

Keywords

  • Acute coronary syndrome
  • Chest pain
  • COVID-19

Fingerprint Dive into the research topics of 'CSANZ Position Statement on the Evaluation of Patients Presenting With Suspected Acute Coronary Syndromes During the COVID-19 Pandemic'. Together they form a unique fingerprint.

Cite this